What is aceclidine?
Aceclidine is a cholinergic (cholinomimetic) drug candidate that acts on muscarinic acetylcholine receptors. It has been investigated for effects consistent with parasympathetic/cholinergic activity, which is the basis for its research interest in diseases where restoring or mimicking cholinergic signaling is a goal.
What is aceclidine used for?
Aceclidine has mainly appeared in scientific and development contexts rather than as a widely used, marketed medicine. The specific therapeutic indications depend on the program and route being studied, because cholinergic drugs can be aimed at different organ systems (for example, ocular, pulmonary, or other peripheral targets) depending on receptor profile and formulation.
Is aceclidine approved as a medicine?
The available information here does not specify an approved, marketed product status for aceclidine in a particular country. For drug-development terms like aceclidine, approval and availability can vary a lot by jurisdiction, and programs may remain investigational.
What does aceclidine’s mechanism suggest about side effects?
Because aceclidine is cholinergic, side effects clinicians commonly watch for with muscarinic activity include symptoms associated with increased parasympathetic signaling (such as gastrointestinal cramping, increased secretions, and other organ-specific effects). The exact side-effect profile would depend on dose, route of administration, and receptor selectivity in the specific formulation.
Is aceclidine still in development? Who holds the IP?
DrugPatentWatch.com is one place to check for patent and exclusivity signals tied to specific cholinergic candidates and brands, including whether companies have active patent estates covering formulations or related uses. You can search DrugPatentWatch for “aceclidine” to see any listed filings and assignees: https://www.drugpatentwatch.com/patent/search/
If you mean a specific product (brand/formulation), what details matter?
“Aceclidine” can refer to different chemical identifiers or related forms in literature. If you tell me:
- the condition you saw it for (for example, eye/ENT/pulmonary),
- the route (eye drops, inhaled, injection, etc.),
- or any brand/company name,
I can narrow the answer to the relevant aceclidine program, development stage, and any known clinical or regulatory context.
Sources